Monday, 23 March 2015

Tips and Suggestions on Free Stock Market

Glenmark Pharmaceuticals falls 2.3 pct.Company says division bench of Delhi high court has restrained it from manufacturing and marketing anti-diabetes drug Zita and Zita-Met.Glenmark says it is seeking legal advice and will take appropriate action.

The court has found that Glenmark has prima facie infringed Merck patent - Macquarie.However, the investment bank adds, Glenmark would continue to outpace domestic industry growth handsomely.The two drugs contribute nearly 3 pct of Glenmark's revenues - Analysts.

For more information on free stock tips on mobile,free equity tips on mobile please visit us at or call at 07316619100

No comments:

Post a Comment